In combination with the reduced incidence of respiratory infections observed here in participants treated with leniolisib, the greater reduction in serum IgM levels reported in this study supports the activity of leniolisib in enabling long-term PI3K signalling normalisation and immune system reconstitution [32]. The gene discussed is CD40LG; the disease is respiratory tract infectious disorder.